SCHEMBL30784264

SCHEMBL30784264

Cc1cc(C(C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)n(C(C)C)c(=O)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 4/20 0.67
▸ AKT2 P31751 4/20 0.67
▸ AKT3 Q9Y243 4/20 0.67
▸ PIK3CA P42336 15/20 0.59
▸ PIK3CB P42338 5/20 0.58
▸ PIK3CD O00329 2/20 0.58
▸ PIK3CG P48736 2/20 0.58
▸ MTOR P42345 2/20 0.58
▸ PRKDC P78527 2/20 0.58
▸ SRC P12931 1/20 0.58
▸ DDX6 P26196 1/20 0.58
▸ PDE4A P27815 1/20 0.58
▸ CSK P41240 1/20 0.58
▸ PLK1 P53350 1/20 0.58
▸ PDE4B Q07343 1/20 0.58
▸ PDE4C Q08493 1/20 0.58
▸ PDE4D Q08499 1/20 0.58
▸ AURKB Q96GD4 1/20 0.58
▸ PI4KB Q9UBF8 1/20 0.58
▸ HDAC6 Q9UBN7 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30784602 0.94 AKT1 (0.65) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30783899 0.94 AKT1 (0.65) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30784111 0.94 AKT1 (0.65) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30784263 0.92 AKT1 (0.56) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30784283 0.91 AKT1 (0.80) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30783640 0.91 AKT1 (0.80) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30783941 0.91 AKT1 (0.80) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30784368 0.89 AKT1 (0.66) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30783879 0.89 AKT1 (0.66) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30784220 0.89 AKT1 (0.66) AKT1AKT2AKT3PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback